Innovent Biologics

About:

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

Website: http://www.innoventbio.com

Twitter/X: Innovent_2011

Top Investors: Temasek Holdings, Sanofi, F-Prime Capital, Cormorant Asset Management, Legend Capital

Description:

Innovent Biologics, Inc. is a privately held biopharmaceutical company dedicated to developing and manufacturing monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by Fidelity's venture arm, a prominent investment firm in the US, Lilly Ventures, and Suzhou bioBay. The registered capital is 30 million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development, and manufacture of biologics in the US, Europe, and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.